Arcus Biosciences, Inc. (RCUS) income statement
RCUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30116% above fair value
$15.62−0.16 (-1.01%)
Close on Nov 20, 2026Market cap $1.99BP/E –Yield –
Arcus Biosciences, Inc. financial ratios
See a number that looks wrong?